Patients who use an app that came with their prescription, from an inhaler tracker to a dose reminder, may soon find that information held to clearer federal standards. On Oct. 20, the FDA finalized guidance on prescription drug apps, explaining how drug companies should label, describe, and submit the content their medication apps show to patients, caregivers, and clinicians.
The stakes are practical. A wrong reminder time, an outdated dosing instruction or an overstated benefit inside an app can shape how someone takes a medicine every day. The guidance treats what these apps display as part of a drug's labeling, which brings that content under FDA oversight.
